Label: NARS ALL DAY LUMINOUS FOUNDATION SIBERIA- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION MONT BLANC- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION DEAUVILLE- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION SWEDEN- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION FIJI- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION PUNJAB- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION SANTA FE- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION BARCELONA- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION LAPONIE- octinoxate and titanium dioxide powder
NARS ALL DAY LUMINOUS FOUNDATION VALLAURIS- octinoxate and titanium dioxide powder
- Label RSS
- Share
-
Contains inactivated NDC Code(s)
NDC Code(s): 13734-129-30, 13734-130-30, 13734-131-30, 13734-132-30, view more13734-133-30, 13734-134-30, 13734-135-30, 13734-136-30, 13734-137-30, 13734-138-30 - Packager: NARS COSMETICS
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated November 26, 2018
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredients
- Purpose
-
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
- Warnings
-
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least every 2 hours
-
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
- children under 6 months: Ask a doctor
-
Inactive ingredients
BORON NITRIDE • SYNTHETIC FLUORPHLOGOPITE • NYLON-12 • LAUROYL LYSINE • DIMETHICONE • JOJOBA ESTERS • SILICA • VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER • TRIETHYLHEXANOIN • DIPHENYL DIMETHICONE/VINYL DIPHENYL DIMETHICONE/SILSESQUIOXANE CROSSPOLYMER • DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER • CELLULOSE • ALUMINUM HYDROXIDE • CAPRYLIC/CAPRIC TRIGLYCERIDE • ALUMINUM DISTEARATE • SORBITAN SESQUIISOSTEARATE • CHLORPHENESIN • MAGNESIUM STEARATE • CRITHMUM MARITIMUM EXTRACT • ASCORBYL GLUCOSIDE • TOCOPHEROL • RETINYL PALMITATE • TOCOPHERYL ACETATE • ASCORBIC ACID • GLYCINE • SEA WATER • WATER • SERINE • GLUTAMIC ACID • ASPARTIC ACID • BHT • BARIUM SULFATE • ALANINE • LYSINE • ARGININE • TYROSINE • PHENYLALANINE • VALINE • THREONINE • PROLINE • ISOLEUCINE • HISTIDINE • LEUCINE • ALGAE EXTRACT • PHENOXYETHANOL • ALUMINA • POTASSIUM SORBATE • CITRIC ACID • [+/- (MAY CONTAIN): MICA • TITANIUM DIOXIDE • IRON OXIDES • BISMUTH OXYCHLORIDE] •
- Other information
- Questions or comments?
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Siberia
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Mont Blanc
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Deauville
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Sweden
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Fiji
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Punjab
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Santa Fe
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Barcelona
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Laponie
- PRINCIPAL DISPLAY PANEL - 12 g Tray Carton - Vallauris
-
INGREDIENTS AND APPEARANCE
NARS ALL DAY LUMINOUS FOUNDATION SIBERIA
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-129 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-129-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 NARS ALL DAY LUMINOUS FOUNDATION MONT BLANC
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-130 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-130-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 NARS ALL DAY LUMINOUS FOUNDATION DEAUVILLE
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-131 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-131-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 NARS ALL DAY LUMINOUS FOUNDATION SWEDEN
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-132 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-132-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 NARS ALL DAY LUMINOUS FOUNDATION FIJI
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-133 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-133-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 NARS ALL DAY LUMINOUS FOUNDATION PUNJAB
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-134 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-134-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 NARS ALL DAY LUMINOUS FOUNDATION SANTA FE
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-135 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-135-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 NARS ALL DAY LUMINOUS FOUNDATION BARCELONA
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-136 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-136-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 NARS ALL DAY LUMINOUS FOUNDATION LAPONIE
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-137 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-137-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 NARS ALL DAY LUMINOUS FOUNDATION VALLAURIS
octinoxate and titanium dioxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13734-138 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 588 mg in 12 g Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 996 mg in 12 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) BORON NITRIDE (UNII: 2U4T60A6YD) BISMUTH OXYCHLORIDE (UNII: 4ZR792I587) NYLON-12 (UNII: 446U8J075B) FERRIC OXIDE RED (UNII: 1K09F3G675) LAUROYL LYSINE (UNII: 113171Q70B) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K) .ALPHA.-CELLULOSE (UNII: I355QGZ19A) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) ALUMINUM DISTEARATE (UNII: 7P1HP1B9UI) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERROSOFERRIC OXIDE (UNII: XM0M87F357) CHLORPHENESIN (UNII: I670DAL4SZ) MAGNESIUM STEARATE (UNII: 70097M6I30) CRITHMUM MARITIMUM (UNII: J7IHY79BKY) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) VITAMIN A PALMITATE (UNII: 1D1K0N0VVC) .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) ASCORBIC ACID (UNII: PQ6CK8PD0R) GLYCINE (UNII: TE7660XO1C) SODIUM CHLORIDE (UNII: 451W47IQ8X) WATER (UNII: 059QF0KO0R) SERINE (UNII: 452VLY9402) GLUTAMIC ACID (UNII: 3KX376GY7L) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ASPARTIC ACID (UNII: 30KYC7MIAI) BARIUM SULFATE (UNII: 25BB7EKE2E) ALANINE (UNII: OF5P57N2ZX) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) TYROSINE (UNII: 42HK56048U) PHENYLALANINE (UNII: 47E5O17Y3R) THREONINE (UNII: 2ZD004190S) VALINE (UNII: HG18B9YRS7) PROLINE (UNII: 9DLQ4CIU6V) ISOLEUCINE (UNII: 04Y7590D77) HISTIDINE (UNII: 4QD397987E) LEUCINE (UNII: GMW67QNF9C) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM OXIDE (UNII: LMI26O6933) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SORBITAN SESQUIISOSTEARATE (UNII: VU97D01BF9) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13734-138-30 1 in 1 CARTON 10/01/2014 1 12 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH NOT FINAL part352 10/01/2014 Labeler - NARS COSMETICS (837363571)
